Status:
COMPLETED
Does Quality of Life Decline During the COVID-19 Pandemic and Can we Change Behaviour to Improve Poor Quality of Life?
Lead Sponsor:
University of Manchester
Conditions:
COVID
Quality of Life
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The response to COVID-19 means social isolation/distancing for the majority of the UK. This has the potential to negatively affect all domains of quality of life (QoL). QoL can be improved by giving f...
Detailed Description
The response to COVID-19 means social isolation/distancing for the majority of the UK. This has the potential to negatively affect all domains of quality of life (QoL). QoL can be improved by giving f...
Eligibility Criteria
Inclusion
- Adults aged 18+ years
- Living in United Kingdom during COVID-19 pandemic.
Exclusion
- English language - all participants are required to be able to read and understand English to participate.
Key Trial Info
Start Date :
May 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
274 Patients enrolled
Trial Details
Trial ID
NCT04522128
Start Date
May 22 2020
End Date
September 1 2021
Last Update
September 30 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Manchester - online
Manchester, Cheshire, United Kingdom, M13 9PT